Anixa Biosciences secured a six-month exclusive right to negotiate a deal for VERDI's cancer vaccines. VERDI’s AI-driven platform develops personalized and off-the-shelf peptide vaccines for ...
US-based integrated energy solutions firm EoS Organization is supporting the development of civil nuclear energy in the Philippines through research, education, and training of the future workforce in ...
While Red Violet is moderately sound financially with its performance catching up to its peers, its valuation is a concern. Based on an optimistic set of assumptions, there is currently no margin ...
On Tuesday, Anixa Biosciences, Inc. (NASDAQ:ANIX) entered into a letter of intent with VERDI Solutions GmbH to develop personalized and off-the-shelf peptide vaccines for cancer patients. VERDI ...
Tenstorrent has built the future of AI architecture and parallel programming. It achieves high performance on current AI models but is flexible and programmable, enabling the invention of future AI ...